• Sylvia Ryz, Johannes Menger, Cecilia Veraar, Philip Datler, Mohamed Mouhieddine, Florentina Zingher, Johannes Geilen, Keso Skhirtladze-Dworschak, AnkersmitHendrik JanHJDepartment of Thoracic Surgery, Medical University of Vienna, Vienna, Austria., Andreas Zuckermann, Edda Tschernko, and Martin Dworschak.
• Division of Cardiothoracic and Vascular Anesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria.
• J. Cardiothorac. Vasc. Anesth. 2024 Feb 1; 38 (2): 445450445-450.

ObjectivesIt remains unclear whether intraoperative lung-protective strategies can reduce the rate of respiratory complications after cardiac surgery, partly because low-risk patients have been studied in the past. The authors established a screening model to easily identify a high-risk group for severe pulmonary complications (ie, pneumonia or acute respiratory distress syndrome) that may be the ideal target population for the assessment of the potential benefits of such measures.DesignRetrospective observational trial.SettingDepartments of cardiac surgery and cardiac anesthesia of a university hospital.ParticipantsConsecutive patients undergoing cardiac surgery on cardiopulmonary bypass and subsequent treatment at a dedicated cardiosurgical intensive care unit between January 2019 and March 2021.InterventionsNone.Measurements And Main ResultsOf the 2,572 patients undergoing surgery, 84 (3.3%) developed pneumonia/acute respiratory distress syndrome that significantly affected the outcome (ie, longer ventilatory support [66% vs 11%], higher reintubation rate [39% vs 3%]), prolonged length of intensive care unit [33 ± 36 vs 4 ± 10 days] and hospital stay [10 ± 15 vs 6 ± 7 days], and higher in-hospital [43% vs 9%] as well as 30-day [7% vs 3%] mortality). The screening model for severe pulmonary complications included left ventricular ejection fraction <52%, EuroSCORE II (European System for Cardiac Operative Risk Evaluation II) >5.9, cardiopulmonary bypass time >123 minutes, left ventricular assist device or aortic repair surgery, and bronchodilatory therapy. A cutoff for the predicted risk of 2.5% showed optimal sensitivity and specificity, with an area under the receiver operating characteristic curve of 0.82.ConclusionsThe authors suggest that future research on intraoperative lung-protective measures focuses on this high-risk population, primarily aiming to mitigate severe forms of postoperative pulmonary dysfunction associated with poor outcomes and increased resource consumption.Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

19 keywords...

hide…